Jeffrey Sevigny
0000-0003-0974-6434
2 papers found
Refreshing results…
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
Patients with autism spectrum disorders display reproducible functional connectivity alterations
Missing publications? Search for publications with a matching author name.